New York: Sat 18 May 17:37 pm
Questcor Pharmaceuticals is not your typical controversial biotech stock — it’s a stock that has rallied from $0.50 in 2005 to $52 today on the strength of its single product called “Acthar Gel,” says Mad Money host Jim Cramer.
With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.
Video © and provided by CNBC.
or give us your opinion and leave a comment.
Be sure to check our RSS feeds for updates.